C84.74
Anaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limb
Clinical Classification Guidelines
Medical Intelligence & Overview
Anaplastic large cell lymphoma (ALCL) is a type of non-Hodgkin lymphoma, which is a cancer that originates in the lymphatic system. When it is classified as ALK-negative, it means that the characteristic protein called anaplastic lymphoma kinase (ALK) is not present in the cancer cells. The specific code C84.74 refers to cases where this condition affects the lymph nodes in the armpits (axilla) and the upper limbs. Though it is a rare form of lymphoma, understanding its features helps in determining the most suitable approach to management.
Causes & Symptoms
Clinical Causes: The exact cause of ALK-negative ALCL remains unknown, but it involves malignant transformation of T lymphocytes, a type of white blood cell. Genetic mutations and abnormalities in immune system regulation may contribute to the development. There is no clear evidence linking environmental factors, infections, or lifestyle habits directly to this specific subtype.
Key Symptoms: Enlarged lymph nodes in the axilla (armpit) and upper limbs, often painless and noticed as swelling. Persistent or recurrent fever. Unexplained weight loss. Night sweats. Fatigue or weakness. Sometimes, symptoms related to compression of nearby structures if lymph nodes enlarge significantly.
Diagnostic & Treatment
Diagnosis Path: Diagnosing ALK-negative ALCL involves several steps to confirm the presence of cancer and its specific subtype. These include:
Treatment Protocols: Chemotherapy remains the main treatment approach, often involving combination regimens tailored to lymphoma. Targeted therapies or immunotherapy may be considered depending on the specific case and available options. Radiation therapy might be used to treat localized areas of disease or after systemic therapy. Stem cell transplantation could be appropriate for certain patients with relapsed or refractory disease. Supportive care, including management of symptoms and side effects, is essential throughout treatment.
Clinical Advice & FAQs
Billing Guidance
Is C84.74 a billable ICD-10 code?
Yes, C84.74 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.74?
Clinical documentation must specify the nature of Anaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limb and any associated comorbidities for accurate reporting.
Cite this Clinical Reference